Home > Books > Immunomodulating Drugs for the Treatment of Cancer
Immunomodulating Drugs for the Treatment of Cancer
View PDF

Immunomodulating Drugs for the Treatment of Cancer

Publication Year: 2011
Edition: 1st Ed.
Authors/Editor: Chanan-Khan, Asher A.
Publisher: Lippincott Williams & Wilkins (LWW)
ISBN: 978-1-605-47333-8
Doody's Star Rating®:  Score: 91
  • Description
  • Details
  • Collections

Immunomodulating Drugs for the Treatment of Cancer brings the most current information on these novel compounds to clinicians and scientists involved in the care of cancer patients.

Immunomodulatory (IMiDs) drugs are a new class of anticancer agents that has made a tremendous impact on the treatment of patients with various malignant diseases, including blood cancers and several cancers of the solid organs. Their popularity in prescribing is based on several important characteristics including: (1) oral bioavailability, (2) non-chemotherapeutic, (3) extremely well-tolerated in all age groups, (4) ability to activate patient's own immune response against cancer, (5) ease of combination with other agents such as chemotherapy resulting in higher responses as well as (6) variability of anticancer activity and a number of cancers. While there is a lot of literature published on these agents, unitl now there has been no textbook that provides a comprehensive resource for clinicians and researchers regarding these agents and their rapidly emerging role in cancer medicine.

The clinical applications of these agents are not limited to oncologists and hematologists, but also impact primary care doctors who care for these patients. Furthermore, new investigations are defining the role of these agents in non-malignant disorders as well.

  • Platform:
    Ovid
  • Publisher: Lippincott Williams & Wilkins (LWW)
  • Product Type: Book
  • Author/Editor: Chanan-Khan, Asher A.
  • ISBN: 978-1-605-47333-8
  • Specialty:
    Hematology
    Oncology
    Primary Care/Family Medicine/General Practice
  • Language: English
  • Edition: 1st Ed.
  • Pages: 312
  • Illustrations: 208
  • Year: 2011
  • Doody's Star Rating®:  Score: 91

Immunomodulating Drugs for the Treatment of Cancer is included in the following Collections:

Free Instant Access
This Month

JOTM
CAB Abstracts The most comprehensive database for applied life sciences, CAB Abstracts gives researchers instant access to over 8.4 million records, with over 360,000 abstracts added each year.
JOTM
Evidence-Based Medicine Reviews (EBMR) A definitive resource for electronic information in the evidence based medicine movement that combines the most trusted resources into a single, fully-searchable database.
JOTM
Continuum: Lifelong Learning in Neurology Helps practicing neurologists to improve patient care, stay abreast of advances in neurology, and develop lifelong, self-directed learning and critical thinking skills.
JOTM
Journal of Healthcare Management Offers timely articles that inform and guide executives, managers, educators, and researchers. It contains regular columns by experts and practitioners on trending topics.

Noteworthy

Doody's Featured Books
The 5-Minute Clinical Consult 2019
A practical, highly organized resource for clinicians in primary care, family medicine, emergency medicine, nursing, and pediatrics. Provides rapid access to guidance on diagnosis, treatment, medications, follow-up, and associated factors for more than 540 diseases and conditions.

Evidence-Based Geriatric Nursing Protocols for Best Practice
This new edition of one of the premier references for geriatric nurses in hospital, long-term, and community settings delivers current guidelines, real-life case studies, and evidence-based protocols developed by master educators and practitioners.